Brief: Eloxx Pharmaceuticals Reports Q2 Loss Per Share Of $0.20

Eloxx Pharmaceuticals

06/08/2020 12:52

Aug 6 (Reuters) - Eloxx Pharmaceuticals Inc  ELOX.O :
    * ELOXX PHARMACEUTICALS REPORTS SECOND QUARTER 2020
FINANCIAL AND
OPERATING RESULTS AND PROVIDES BUSINESS UPDATE
    * Q2 LOSS PER SHARE $0.20
    * Q2 EARNINGS PER SHARE ESTIMATE $-0.21 -- REFINITIV IBES
DATA
    * EXPECT CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES
WILL BE
SUFFICIENT TO FUND OPERATIONS THROUGH END OF 2021

Source text for Eikon:  ID:nGNX7M77xv 
Further company coverage:  ELOX.O 

 ((Reuters.Briefs@thomsonreuters.com;))